Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines. Its mission is to deliver the right medicine to the right patient at the right time.
Clinigen is focused in three areas of global medicine supply: clinical trial, unlicensed and licensed medicines.
Clinigen is the global market leader in the management and supply of commercial medicines for clinical trials.
The Group is also the trusted global leader in ethically sourcing and supplying unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet need. Clinigen runs early access programs for innovative new medicines, and works directly with healthcare professionals to enable compliant access to unlicensed medicines on a global basis and niche essential licensed and generic medicines across Australasia, Africa and Asia (AAA region).
Clinigen’s Specialty Pharmaceuticals business acquires global rights, revitalises and markets its own portfolio of niche hospital products.
For more information, please visit www.clinigengroup.com